Some patients may benefit from very low-calorie diets (800 kcal/day) under medical supervision, particularly those with type 2 diabetes or significant obesity-related complications, as outlined in NICE CG189
aunque la causalidad no est completamente establecida, se recomienda suspender el tratamiento y evaluar ante dolor abdominal severo
Vcut yalarnn azalmasn isteyen obezite hastalarnn her gn 1,8 ile 7 gram arasnda CLA takviyesi kullanmalar nerilir
The prevalence of gastrointestinal adverse events underscores the importance of patient education before initiating semaglutide therapy, including strategies for minimizing discomfort and recognizing warning signs that merit medical attention
Pharmaceutical research , 16 (9), 14121416
Most clinical trials have shown it is well accepted by most patients and the side effects have mostly been negligible and very few have occurred